A detailed history of Range Financial Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Range Financial Group LLC holds 9,827 shares of NVO stock, worth $1.41 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
9,827
Previous 9,833 0.06%
Holding current value
$1.41 Million
Previous $1.02 Million 23.99%
% of portfolio
0.66%
Previous 0.62%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$102.11 - $135.92 $612 - $815
-6 Reduced 0.06%
9,827 $1.26 Million
Q4 2023

Jan 10, 2024

SELL
$87.78 - $105.45 $51,000 - $61,266
-581 Reduced 5.58%
9,833 $1.02 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $441,149 - $967,968
4,851 Added 87.2%
10,414 $947,000
Q2 2023

Jul 18, 2023

SELL
$155.98 - $172.65 $109,341 - $121,027
-701 Reduced 11.19%
5,563 $900,000
Q1 2023

Apr 03, 2023

SELL
$132.34 - $159.14 $120,164 - $144,499
-908 Reduced 12.66%
6,264 $996,000
Q4 2022

Jan 13, 2023

BUY
$102.55 - $135.33 $17,536 - $23,141
171 Added 2.44%
7,172 $0
Q3 2022

Oct 13, 2022

SELL
$95.28 - $116.93 $12,291 - $15,083
-129 Reduced 1.81%
7,001 $698,000
Q2 2022

Jul 11, 2022

SELL
$103.24 - $121.81 $38,818 - $45,800
-376 Reduced 5.01%
7,130 $794,000
Q1 2022

May 18, 2022

SELL
$93.1 - $112.54 $1.52 Million - $1.84 Million
-16,329 Reduced 68.51%
7,506 $834,000
Q4 2021

Jul 11, 2022

SELL
$95.88 - $117.08 $106,426 - $129,958
-1,110 Reduced 4.45%
23,835 $2.67 Million
Q3 2021

Jul 11, 2022

SELL
$84.42 - $106.62 $219,238 - $276,892
-2,597 Reduced 9.43%
24,945 $2.4 Million
Q2 2021

Jul 11, 2022

BUY
$67.66 - $84.76 $246,891 - $309,289
3,649 Added 15.27%
27,542 $2.31 Million
Q1 2021

Jul 11, 2022

BUY
$67.06 - $75.82 $1.6 Million - $1.81 Million
23,893 New
23,893 $1.61 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Range Financial Group LLC Portfolio

Follow Range Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Range Financial Group LLC with notifications on news.